BDNF Val66Met may be associated with variability in post-stroke cognitive outcomes, particularly global cognition and memory, however, population-specific findings and methodological heterogeneity preclude definitive conclusions.
Abstract
Post-stroke cognitive impairment (PSCI) is a common and disabling consequence of stroke. Brain-derived neurotrophic factor (BDNF) plays important roles in neuroplasticity, and the BDNF Val66Met (rs6265) polymorphism may alter cognitive outcomes after stroke; however, evidence remains inconsistent. We searched PubMed, Scopus, and Web of Science. Observational studies involving adults with stroke that evaluated the association between BDNF Val66Met and post-stroke cognitive outcomes were included. Two reviewers independently screened studies; one reviewer extracted and another verified the data. Methodological quality was assessed using the Newcastle–Ottawa Scale. Findings were synthesized narratively because of substantial heterogeneity in study population, genotype classification, and cognitive measures. Seven studies involving 2,494 participants met the inclusion criteria. Five studies evaluated global cognitive outcomes. Four reported significant genotype-related associations or differences in global cognition, with three showing poorer cognitive outcomes among Met-allele carriers and one reporting the opposite direction. In the largest cohort, Met carriers had significantly lower 12-month telephone Montreal Cognitive Assessment scores after adjustment for covariates. Memory was the most consistently affected domain, with poorer performance among Met carriers. Evidence for language was inconsistent, while data on attention and executive function were limited. One cohort reported an opposite association, with Val-allele carriers demonstrating poorer global cognition and language performance. One study also identified poorer cognitive functional recovery among Met carriers. BDNF Val66Met may be associated with variability in post-stroke cognitive outcomes, particularly global cognition and memory. However, population-specific findings and methodological heterogeneity preclude definitive conclusions. Larger prospective multicenter studies using standardized cognitive assessments are warranted.
Background Brain-derived neurotrophic factor (BDNF) has been proposed as a neuroimmune biomarker of cognitive dysfunction in paediatric neurodevelopmental disorders other than autism spectrum disorder, but two related questions remain poorly characterised: whether circulating BDNF differs between affected and unaffecte...
Begüm Çapa Tayyare, B. Yuksel, Nurullah Eryilmaz· Frontiers in Neurology· 1 citation
Objective: To evaluate the association between cord-blood or early neonatal brain-derived neurotrophic factor (BDNF) concentrations and neurodevelopmental outcomes during the first three years of life. Methods: This systematic review and meta-analysis followed PRISMA 2020. PubMed, ScienceDirect, and SpringerLink were s...
Aswin Boy Pratama, Jamsari Jamsari, Hardisman Hardisman et al.· Majalah Kedokteran Andalas· 0 citations
Brain-derived neurotrophic factor (BDNF) plays a crucial role in neuroprotection and neuroplasticity, positioning it as a key target for enhancing rehabilitation outcomes in stroke survivors. This scoping review aimed to explore the relevance of serum BDNF levels in improving trunk control and balance performance among...
Abdulkareem Muhammad Umar, M. Sharifudin, Naresh Bhaskar Raj et al.· IIUM Medical Journal Malaysi...· 0 citations
Brain-derived neurotrophic factor (BDNF) supports neuroprotection and neuroplasticity, and its functional Val66Met polymorphism has been linked to heterogeneous clinical and MRI phenotypes in multiple sclerosis (MS). We investigated the medium-term effect of Val66Met compared with Val66Val status (wild-type) to disab...
E. de Meo, I. Addazio, R. Bonacchi et al.· Brain Communications· 0 citations
Background Brain-derived neurotrophic factor (BDNF) is a key mediator of neuroplasticity and has been associated with disease progression in multiple sclerosis (MS). While aerobic exercise is consistently linked to BDNF modulation, the specific contribution of isolated resistance training (RT) remains unclear, as previ...
W. R. Pedon, G. de Conti Teixeira Costa, Lorenzo de Ávila Rodrigues Cortizo Vidal et al.· PLoS ONE· 0 citations
The three-level meta-analysis revealed that multicomponent exercise significantly improved global cognitive function and executive function in older adults with MCI and BDNF was assessed in only two studies, with conflicting findings.
Peng-Fei Yang, Yong-Jie Liu, Yi-Yi Duan et al.· Frontiers in Aging Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.